About the Oncomine Clinical Research Grant Program

The Oncomine Clinical Research Grant Program supports investigator-initiated studies (IIS) and education projects on molecular profiling in oncology, with the goal to increase high quality molecular profiling and help democratize the future of precision medicine. Proposal reviews are conducted by independent and internationally recognized experts together with Thermo Fisher Scientific medical and scientific leadership. Funding is considered based on scientific merit.

 

The application process is managed by the Oncomine Clinical Research Grant Office, part of the Medical Affairs team of the Clinical Sequencing Division at Thermo Fisher Scientific. For detailed information about how to apply, including documentation requirements, review process, and decision notification, refer to the Guidelines for Applicants.   

 

Grant applications should be submitted electronically (English only) using the application form below. Proposals should outline the planned activities to be performed within a maximum of 12 months. A budget is required for every grant request and should detail the proposed use of the requested funds. The maximum budget request for each project is set at $200,000.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Apply for the Oncomine Clinical Research Grant Program

      Applications for the Oncomine Grant program are now closed.

       

      The next application period will open September 1st  – October 3rd, 2025.

       

       

      Submitting Your Application

      Proposals will be accepted through the submission portal during open submission period. Alternatively we may accept via the email medical.affairs@thermofisher.com. Please visit this web page during the open submission period to submit your application.

      oncomine-grant

      Grant selection process overview

      The evaluation process is performed by a committee of external experts in the field, along with Thermo Fisher Scientific medical and scientific leadership. The committee selects awardees based on the scientific merit of the proposed project.

      grant-process

      Step 1: Submission

      Submission is done by emailing the application form to medical.affairs@thermofisher.com or by using the online grant management portal.

       

      Step 2: Evaluation

      Submissions are confirmed by the grant office via email. Decisions are communicated 6 to 8 weeks after the end of the submission period.

       

      Step 3: Execution

      Upon contract signature, the requested support will be granted. The grant office team will continue to support the development of the awarded project. A final report is due to the grant office team within the agreed time frame.

       

      Note: The financial support will be made in accordance with local legislation.


      Hear from the awardees

      Brandon Sheffield

      “The Oncomine Grant program gives a chance to those who wouldn’t otherwise have it to be able to work with next-generation sequencing technologies. The funding from the Oncomine Grant program can really help us overcome one of the biggest hurdles for smaller and less funded centers to be able to work with these types of emerging technologies.”

       

      Brandon Sheffield, MD
      William Osler Health System, Canada
      2020 Oncomine Clinical Research Grant awardee

      Elena Guerini Rocco

      “Industry funding [like the Oncomine Clinical Research Grant program] is important because it can generate a sort of virtual circle, creating a link between the industry and different academic institutions and hospital research labs, and this link can foster the development and the implementation of new platforms or new assays focused on the unmet clinical needs of the future.”

       

      Elena Guerini Rocco, MD
      European Institute of Oncology IRCCS, Italy
      2021 Oncomine Clinical Research Grant awardee

      Elin Gray

      “The opportunity the Oncomine Grant has afforded us to work on the analysis of the
      T cell repertoire has opened also a number of opportunities for my team to collaborate on larger studies. We are now moving from the analysis that we have done with the Oncomine Grant to a large study at the national level to further evaluate these biomarkers and the T cell repertoire.”

       

      Elin Gray, PhD
      Edith Cowan University, Australia
      2021 Oncomine Clinical Research Grant awardee


      Tips for submitting a strong grant proposal

      Optimizing your laboratory’s application for the Oncomine Clinical Research Grant requires a clear proposal that meets the criteria and priorities of program. Here are some general tips that can help you in the grant application process:

       

      1. Develop a comprehensive research proposal: Your research proposal should be clear, concise, and convincing. It should explain the rationale, significance, and objectives of your study. You should also describe your research methods, expected outcomes, and results communication plan.

       

      2. Demonstrate your qualifications: Highlight your previous research experience, publications, and relevant skills. If appropriate include a description of the broader team that will be involved in the project and their roles.

       

      3. Identify your research needs: Create a detailed list that includes all the necessary expenses and supplies. Make sure that your needs align with the grant program’s guidelines and expectations.

       

      4. Submit your application: Ensure that you have followed all the application guidelines and provided all the necessary information before submitting.


      Have questions?

      For any questions about the Oncomine Clinical Research Grant Program, please email medical.affairs@thermofisher.com.

      For Research Use Only. Not for use in diagnostic procedures.